May 24, 2016 / 6:41 AM / a year ago

BRIEF-Zhejiang Hisun Pharmaceutical receives clinical trial permission

May 24 (Reuters) - Zhejiang Hisun Pharmaceutical Co.,Ltd.:

* Receives clinical trial permission from State Food and Drug Administration, for fidaxomicin

Source text in Chinese: me2.do/G3blaw4c

Further company Coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below